STRUCTURE-ACTIVITY-RELATIONSHIPS OF 9-ALKYLADENINE AND RIBOSE-MODIFIED ADENOSINE DERIVATIVES AT RAT A(3) ADENOSINE RECEPTORS

被引:62
作者
JACOBSON, KA
SIDDIQI, SM
OLAH, ME
JI, XD
MELMAN, N
BELLAMKONDA, K
MESHULAM, Y
STILES, GL
KIM, HO
机构
[1] DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710
关键词
D O I
10.1021/jm00010a017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
9-Alkyladenine derivatives and ribose-modified N-6-benzyladenosine derivatives were synthesized in an effort to identify selective ligands for the rat A(3) adenosine receptor and leads for the development of antagonists. The derivatives contained structural features previously determined to be important for A(3) selectivity in adenosine derivatives, such as an N-6-(3-iodobenzyl) moiety, and were further substituted at the 2-position with halo, amino, or thio groups. Affinity was determined in radioligand binding assays at rat brain A(3) receptors stably expressed in Chinese hamster ovary (CHO) cells, using [I-125]]AB-MECA (N-6-(4-amino-3-iodobenzyl)adenosine-5'-(N-methyluronamid)), and at rat brain A(1) and A(2a) receptors using [H-3]-N-6-PIA ((R)-N-6-phenylisopropyladenosine) and [H-3]CGS 21680 (2-[[[4-(2-carboxyethyl)-phenyl]ethyl]amino]-5'-(N-ethylcarbamoyl)adenosine), respectively. A series of N-6-(3-iodobenzyl) 2-amino derivatives indicated that a small 2-alkylamino group, e.g., methylamino, was favored at A(3) receptors. N-6-(3-Iodobenzyl)-9-methyl-2-(methylthio)adenine was 61-fold more potent than the corresponding 2-methoxy ether at A(3) receptors and of comparable affinity at A(1) and A(2a) receptors, resulting in a 3-6-fold selectivity for A(3) receptors. A pair of chiral N-6-(3-iodobenzyl) 9-(2,3-dihydroxypropyl) derivatives showed stereoselectivity, with the R-enantiomer favored at A(3) receptors by 5.7-fold. 2-Chloro-9-(beta-D-erythrofuranosyl)-N-6-(3-iodobenzyl)adenine had a K-i value at A(3) receptors of 0.28 mu M. 2-Chloro-9-[2-amino-2,3-dideoxy-beta-D-5-(methylcarbamoyl)-arabinofuranosyl]-N-6-(3-iodobenzyl)adenine was moderately selective for A(1) and A(3) VS A(2a) receptors. A 3'-deoxy analogue of a highly A(3)-selective adenosine derivative retained selectivity in binding and was a full agonist in the inhibition of adenylyl cyclase mediated via cloned rat A(3) receptors expressed in CHO cells. The 3'-OH and 4'-CH2OH groups of adenosine are not required for activation at A(3) receptors. A number of 2',3'-dideoxyadenosines and 9-acyclic-substituted adenines appear to inhibit adenylyl cyclase at the allosteric ''P'' site.
引用
收藏
页码:1720 / 1735
页数:16
相关论文
共 43 条
[1]  
BAI TR, 1994, DRUG DEVELOP RES, V31, P244
[2]  
BEAVEN MA, 1994, TRENDS PHARMACOL SCI, V15, P13, DOI 10.1016/0165-6147(94)90124-4
[3]  
BRNS RF, 1981, BIOCHEM PHARMACOL, V30, P325
[4]  
BRUNS RF, 1980, CAN J PHYSIOL PHARM, V58, P673, DOI 10.1139/y80-110
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]  
DALY JW, 1995, ADENOSINE AND ADENINE NUCLEOTIDES: FROM MOLECULAR BIOLOGY TO INTEGRATIVE PHYSIOLOGY, P157
[7]   AGONIST ACTIVITY OF 2-SUBSTITUTED AND 5'-SUBSTITUTED ADENOSINE-ANALOGS AND THEIR N6-CYCLOALKYL DERIVATIVES AT ADENOSINE-A1 AND ADENOSINE-A2 RECEPTORS COUPLED TO ADENYLATE-CYCLASE [J].
DALY, JW ;
PADGETT, WL .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (05) :1089-1093
[8]   ADENOSINE-A(3) RECEPTORS MEDIATE HYPOTENSION IN THE ANGIOTENSIN II-SUPPORTED CIRCULATION OF THE PITHED RAT [J].
FOZARD, JR ;
CARRUTHERS, AM .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (01) :3-5
[9]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF N-6-BENZYLADENOSINE-5'-URONAMIDES AS A(3)-SELECTIVE ADENOSINE AGONISTS [J].
GALLORODRIGUEZ, C ;
JI, XD ;
MELMAN, N ;
SIEGMAN, BD ;
SANDERS, LH ;
ORLINA, J ;
FISCHER, B ;
PU, QL ;
OLAH, ME ;
VANGALEN, PJM ;
STILES, GL ;
JACOBSON, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) :636-646
[10]   REVERSAL OF SYNAPTIC DEPRESSION BY SEROTONIN AT APLYSIA SENSORY NEURON SYNAPSES INVOLVES ACTIVATION OF ADENYLYL CYCLASE [J].
GOLDSMITH, BA ;
ABRAMS, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :9021-9025